Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
SELUTION Denovo

Video Series

Author(s): Peter O’Kane , Simon Eccleshall , Andrew Vanezis , et al Added: 4 months ago
This programme provides a practical, evidence-led review of drug-coated balloons in DeNovo coronary lesions. It examines the latest clinical data supporting DCB use and translates findings into decision-making for everyday PCI.The content builds procedural confidence in DCB-based PCI, with emphasis on lesion preparation, intracoronary imaging techniques and optimal device delivery. Faculty also… View more
Author(s): Matthias Götberg Added: 7 months ago
Prof Matthias Götberg (Interventional Cardiologist at Skane University Hospital, Lund, SE) provides an overview of the recent two-year data presented from the SCAAR registry and an overview of the bifurcation subset analysis that was presented at EuroPCR in May 2025.Prof Götberg is a contributor to The Swedish Coronary Angiography and Angioplasty Registry (SCAAR), he discusses the key findings… View more
Author(s): Matthias Bossard Added: 7 months ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus… View more
Added: 2 months ago Source:  ICR3 Journal Radcliffe Cardiology
The optimal timing for treating nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease remains a topic of clinical debate. The iMODERN trial sought to clarify this by comparing outcomes between an immediate, physiology-guided percutaneous coronary intervention (PCI) strategy and a deferred, imaging-guided approach.¹˒²MethodologyThe… View more
Author(s): Sahil Parikh Added: 7 months ago
TCT 2025 - Three-year findings from LIFE-BTK show the Esprit™ BTK scaffold is a durable and effective treatment option for patients with CLTI.Dr Sahil Parikh (Columbia University Vagelos College of Physicians & Surgeons, New York, US) joins us to share the three-year findings from LIFE-BTK (NCT04227899). The randomized controlled trial aimed to evaluate the safety and efficacy of the Esprit™ BTK… View more